TERINA WILLIAMS: Open Payments
NPI 1528461845 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,867 in 85 payments from 23 companies in 2025. Trend: 2023 $574 · 2024 $1,522 · 2025 $1,867
Food & beverage: $1,830Education: $37
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 8 | $207 |
| Mallinckrodt Hospital Products Inc. | 6 | $191 |
| Otsuka America Pharmaceutical, Inc. | 8 | $185 |
| Fresenius USA Marketing, Inc. | 7 | $150 |
| Amgen Inc. | 7 | $148 |
| Novartis Pharmaceuticals Corporation | 7 | $137 |
| Ardelyx, Inc. | 6 | $125 |
| ANI Pharmaceuticals, Inc. | 4 | $106 |
| Novo Nordisk Inc | 5 | $83 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
Products named: TARPEYO, ACTHAR, JYNARQUE, VELPHORO, IBSRELA, Fabhalta, PURIFIED CORTROPHIN GEL, JARDIANCE.
Industry payments across DE — which companies pay providers there.
